MedTrace Logo

Performance Determinants Factors in Elite Endurance Athletes.

NCT03569566 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 54

Last updated 2022-08-04

No results posted yet for this study

Summary

Several studies have investigated determinant factors for endurance performance among different athletes, untrained individuals and patients focusing on the impact of age, genes and training intensity. A further step in this research will be to investigate the impact of age, genes, training intensity and history of tick-bourne disease on endurance performance in elite endurance athletes. We are planning a project with a two-step model. In step one we will, in a cross-sectional study design, investigate potential relationships between age, training intensity, training volume, genes, exosomes and history of tick-bourne disease and physiological variables and endurance performance. In step two we will investigate differences in training adaptation by observing and monitoring all training done by the participants during a 6-months period. The participants will be tested for several physiological variables before, after 3- months and after this period. We will also investigate the impact of age, training intensity, training volume, genes and history of tick-bourne disease on the results from the physiological tests and performance.

Conditions

  • Exercise Physiology

Interventions

OTHER

Age, Genes, Training, Tickbourne Disease and Endurance

Testing of genes, exosomes, physiological variables, tick-bourne disease markers, observation of training modality and performance

Sponsors & Collaborators

  • Norwegian University of Science and Technology

    collaborator OTHER

  • University of South-Eastern Norway

    lead OTHER

Principal Investigators

  • Pål Augestad, PhD · University of South-Eastern Norway

Eligibility

Min Age
16 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-06-27
Primary Completion
2021-12-31
Completion
2021-12-31

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03569566 on ClinicalTrials.gov